Has the 23-day lockout requirement been eliminated for Female Patients Not of Childbearing Potential and Male Patients?
Yes. The 23-day lockout period has been eliminated for female patients not of childbearing potential and male patients . Previously, whether a prescription was filled or not, a female patient not of childbearing potential or male patient could not start the qualification process for another prescription until 23 days after the end of his/her prescription window. While the prescribing procedures and qualification criteria for isotretinoin will remain the same, the elimination of the 23-day lockout period will allow female patients not of childbearing potential and male patients the ability to re-qualify and have a new prescription filled immediately after his/her prescription window has expired. • Please explain the extension of the prescription window for Female Patients Not of Childbearing Potential and Males. Effective immediately, the prescription window for female patients not of childbearing potential and males has been extended from 7 days to 30 days. Previously, once all require
Related Questions
- How does the elimination of the 23-day lockout for Female Patients of Childbearing Potential affect pharmacy requirements to obtain prescription authorizations?
- Has the 23-day lockout requirement been eliminated for Female Patients Not of Childbearing Potential and Male Patients?
- Has the 23-day lockout requirement been eliminated for Female Patients of Childbearing Potential?
